Barry Callebaut USA Recall (March 2025): CACAO BARRY Gianduja Noir

On March 22, 2025, Barry Callebaut USA LLC began a Class II recall. Reason: Undeclared milk.

In plain words

What

CACAO BARRY Gianduja Noir, 5.5lbs (2.5kg) plastic bucket, 8 buckets per case.

Why

Undeclared milk

Where

California, Florida, Georgia, Nevada, New York, Pennsylvania, Texas, Virginia.

Distribution as reported to FDA: NV, NY, GA, TX, VA, CA, PA, FL

How serious

Class II: the FDA uses this class for a situation where eating the product may cause temporary or medically reversible health problems, or where the chance of serious health problems is remote.

Status: Terminated. FDA has closed the recall. Closed August 8, 2025.

What to do

Compare the product name, size, UPC and lot or date codes below with what you have. The FDA Enforcement Report is the official record of this recall; for instructions on returns or refunds, follow the notice or contact Barry Callebaut USA LLC.

Official notice ↗

The recalled product1

FDA recall F-0719-2025 · Class II · Terminated

CACAO BARRY Gianduja Noir, 5.5lbs (2.5kg) plastic bucket, 8 buckets per case.

Codes:
Lot: 2428415339
Quantity:
180 cases

Recall record

Agency
U.S. Food and Drug Administration (FDA)
Recalling firm
Barry Callebaut USA LLC, Chicago, IL
Recall started
March 22, 2025
FDA Enforcement Report
April 9, 2025
Initiated
Voluntary: Firm initiated
Recall number
F-0719-2025
FDA event ID
96572

Latest food recalls

JXK Enterprises, Inc is voluntarily recalling Boner Bears Chocolate, Lot #BB21125, after being notified that FDA laboratory analysis confirmed the presence of sildenafil, an active ingredient in the FDA-approved prescription drug Viagra, which is not declared on the product label.

Nationwide · Ongoing

All food recalls

Recall details come from the U.S. Food and Drug Administration's Enforcement Reports (through openFDA) and from USDA's Food Safety and Inspection Service recalls and public health alerts, checked daily. MealSlash shows what the agency published and links every recall to its official notice; the notice is the authority. openFDA's note: do not rely on openFDA to make decisions regarding medical care.